The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Ricardo J. Bello, Carisa M. Cooney, Eitan Melamed, Keith Follmar, Gayane Yenokyan, Gwendolyn Leatherman, Ami A. Shah, Fredrick M. Wigley, Laura K. Hummers, Scott D. Lifchez

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma-Associated Raynaud's Phenomenon: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences